← Open Payments lookup

MICHAEL BLOCKER: Open Payments

NPI 1487134052 · NAVARRE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$879 in 45 payments from 15 companies in 2025. Trend: 2023 $356 · 2024 $423 · 2025 $879

Food & beverage: $879
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$258
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$107
Corium, LLC3$92
Amgen Inc.4$62
Bayer Healthcare Pharmaceuticals Inc.3$59
Otsuka America Pharmaceutical, Inc.3$52
GlaxoSmithKline, LLC.3$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Takeda Pharmaceuticals U.S.A., Inc.2$38
Axsome Therapeutics, Inc.1$25

Products named: AIRSUPRA, XIFAXAN, Azstarys, EVENITY, Kerendia, REXULTI, FARXIGA, CAPLYTA.

Industry payments across FL — which companies pay providers there.